Work

Long-Term Follow-up of Idelalisib Monotherapy in Patients with Double-Refractory Marginal Zone Lymphoma or Lymphoplasmacytic Lymphoma/ Waldenstrom's Macroglobulinemia

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-121936

Authors: Nina D. Wagner-Johnston, Stephen J. Schuster, Sven de Vos, Gilles A. Salles, Wojciech Jurczak, Nishan Rajakumaraswamy, Guan Xing, Ajay K. Gopal

Institutions: Johns Hopkins University, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, Abramson Cancer Center, University of Pennsylvania, University of California, Los Angeles, Hospices Civils de Lyon, Jagiellonian University, Gilead Sciences (United States), Seattle Cancer Care Alliance

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2986668065

Cites:

Cited by: 6

Related to: 10